Skip to main content

Table 6 Genes upregulated between 15- and 20-fold in peripheral blood mononuclear cells of patients with stable COPD or AECOPD compared with healthy control subjects a

From: Dynamic gene expressions of peripheral blood mononuclear cells in patients with acute exacerbation of chronic obstructive pulmonary disease: a preliminary study

Stable vs control

AE-1 vs control

AE-3 vs control

AE-10 vs control

Fold changes

Genes

Fold changes

Genes

Fold changes

Genes

Fold changes

Genes

15.2

LOC645558

15.0

CNN3

15.0

GPR109B

15.0

USP54

15.7

N/A

15.0

GPT2

15.0

LOC653492

15.0

MGC45438

15.9

LOC653455

15.1

ORM1

15.2

RNASE1

15.2

SLCO2A1

15.9

DUX4

15.1

LOC402110

15.3

FN1

15.3

AGER

16.1

LOC653768

15.1

MDK

15.5

ACSL1

15.3

FLJ11259

16.5

RAB17

15.2

ELF3

15.5

CDH5

15.5

CLEC3B

16.6

LOC653541

15.2

PSG8

15.6

FOLR3

15.8

ADCY4

16.6

LOC391763

15.3

SLC25A37

15.8

PVRL2

16.0

FN1

16.7

LOC642286

15.4

FKBP9

15.9

KRT19

16.1

HP

16.7

S100A14

15.5

C1QB

15.9

MDK

16.1

CKB

16.7

NBPF9

15.6

BPGM

16.0

APOC1

16.1

CYP4B1

16.9

PSG8

15.7

AQP9

16.3

NOL3

16.2

RARRES2

17.0

REXO1L6P

15.7

LOC402207

16.3

ATP1B1

16.3

TSPAN1

17.0

MLPH

15.7

PSG11

16.4

TMC4

16.6

SDC4

17.1

FAM90A7

16.0

KLK11

16.4

VEGF

16.7

ERG

17.4

LOC401650

16.2

KIAA0703

16.6

SPAG4

16.8

LOC653107

17.8

DUB3

16.2

IGFBP5

16.8

LIF

17.2

RAB25

17.9

MGC45438

16.2

IGFBP3

16.8

CCDC80

17.2

COL1A2

18.9

COL3A1

16.2

N/A

16.9

CEACAM3

17.3

DCN

19.1

LOC645732

16.2

SLC25A37

16.9

IGFBP3

17.5

TSPAN13

19.8

LOC392188

16.3

SIX1

17.1

CXCL2

17.6

HSD17B6

20.0

MUC1

16.3

LOC645009

17.2

FKBP9

17.8

RHOB

  

16.4

C1QA

17.2

CEACAM1

17.9

KRT19

  

16.5

UBD

17.7

ELF3

18.0

AQP9

  

16.6

LOC653342

17.7

CNN3

18.2

FOLR1

  

17.0

GPR97

17.8

PGLYRP1

18.2

IL1RL1

  

17.1

COL1A1

17.9

KRT23

18.2

SERPING1

  

17.3

ALPL

18.1

SLC44A4

18.3

MGC35295

  

17.4

FBLN1

18.1

SCNN1A

18.4

FLJ43663

  

17.5

HIG2

18.4

FBLN1

18.6

TGM2

  

17.7

COL8A1

18.5

HPR

18.6

ADH1C

  

17.9

TMC5

18.6

SYT7

18.7

KIAA1026

  

18.1

LTBP2

18.6

CEACAM8

19.1

DKFZP686A01247

  

18.4

SLC25A37

18.8

C1R

19.2

CCDC48

  

18.7

CEACAM3

18.8

COL1A1

19.2

ANKRD25

  

18.9

MPO

18.9

COL8A1

19.3

DMBT1

  

19.0

CD24

18.9

C1QC

19.4

MALL

  

19.0

CHI3L1

18.9

SFRP2

19.5

ANXA8

  

19.0

DCN

19.0

HIG2

19.5

SPRY4

  

19.1

P8

19.2

C1QB

19.7

ELF3

  

19.1

CEACAM6

19.2

GPRC5A

19.9

EHD2

  

19.1

ACSL1

19.3

MMP25

20.0

DCN

  

19.5

PRTN3

19.3

UBD

  
  

19.5

LIF

19.3

GADD45A

  
  

19.6

LTF

19.4

ISLR

  
  

19.7

ANXA3

19.5

ORM1

  
  

19.7

C1R

19.5

C20orf114

  
  

19.7

MUC1

19.5

LOC203510

  
  

19.8

PSG4

19.6

DCN

  
  

19.9

HP

19.7

FN1

  
    

19.8

DAAM2

  
    

19.9

FOLR3

  
  1. aData are from patients with stable chronic obstructive pulmonary disease (Stable) or acute exacerbation of chronic obstructive pulmonary disease on day 1 (AE-1), day 3 (AE-3) and day 10 (AE-10) of hospital admission, as compared to healthy controls.